AKYNZEO

knight therapeutics inc.🇨🇦 Health Canada

Approval Id: 74abcab8082148ee
Drug Approval Canada Name: AKYNZEO
Product Name: AKYNZEO
Status: Marketed
Status Date: 2022-11-30
Original Market Date: 2017-11-20
Din: 02468735
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 56:22.00
Atc Original: A04AA55 PALONOSETRON, COMBINATIONS
Atc Name: a 04 aa 55
Aig Number: 0259550001
Company Name: knight therapeutics inc.
Company Address: 1055, 3400 De Maisonneuve Blvd W, Montreal, Quebec, Canada, H3Z 3B8

NETUPITANT

300 MG

PALONOSETRON (PALONOSETRON HYDROCHLORIDE)

0.5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

74abcab8082148ee

Type

Standard